Suzanne L. Bruhn
Signal active
CEO
Contact Information
Social
Primary Organization
CMTA
Founded
1983
Investment
1
Lead investment
1
Exits
0
Employees
11-50
Industry
Non Profit
Bio
Suzanne L. Bruhn is the CEO of CMTA. She previously worked at Tiaki Therapeutics as a CEO and President. Suzanne L. Bruhn attended the Massachusetts Institute of Technology.
Location
Boston, Massachusetts, United States, North America
Jobs history
6
CMTA
CEO
2023 - Current
MindMed
Board Member
2022 - Current
Vigil Neuroscience
Board Member
2022 - Current
Travere Therapeutics
Board Member
2020 - Current
CEO and President
2019 - 2023
Proclara Biosciences
CEO and President
2017 - 2018
Educations
2
Massachusetts Institute of Technology
unknown
Iowa State University
Chemistry
Profile Resume
Suzanne L. Bruhn is the CEO at CMTA, based in United States, North America. With a background in Non Profit, Suzanne L. Bruhn has a rich history of leadership and innovation.Suzanne L. Bruhn studied Ph.D unknown at Massachusetts Institute of Technology. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.